4basebio (XTER:88Q) Price-to-Operating-Cash-Flow : (As of May. 17, 2024)

View and export this data going back to 2021. Start your Free Trial

What is 4basebio Price-to-Operating-Cash-Flow?

As of today (2024-05-17), 4basebio's share price is €16.60. 4basebio's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.49. Hence, 4basebio's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for 4basebio's Price-to-Operating-Cash-Flow or its related term are showing as below:

XTER:88Q's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.395
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

4basebio's Cash Flow from Operations per share for the six months ended in Jun. 2023 was €-0.28. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.49.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -158.90% per year.

During the past 4 years, 4basebio's highest 3-Year average Operating Cash Flow per Share Growth Rate was -158.90% per year. The lowest was -158.90% per year. And the median was -158.90% per year.

4basebio Price-to-Operating-Cash-Flow Historical Data

The historical data trend for 4basebio's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Price-to-Operating-Cash-Flow Chart

4basebio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

4basebio Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of 4basebio's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, 4basebio's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4basebio's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4basebio's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where 4basebio's Price-to-Operating-Cash-Flow falls into.

4basebio Price-to-Operating-Cash-Flow Calculation

4basebio's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	16.60	/	-0.492
	=

4basebio's Share Price of today is €16.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 4basebio's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.49.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

4basebio Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of 4basebio's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (XTER:88Q) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

4BB:UK

Address

25 Norman Way, Over, Cambridge, GBR, CB24 5QE

Website

https://www.4basebio.com

4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (XTER:88Q) Headlines

No Headlines